Pardes Biosciences OverviewTrack Pardes Biosciences's gross profit ($0) with charts, peers, and YoY trends.
Get informed when a big investor buys or sells
+ FollowAs of Jun 30, 2023
Trailing 12 months ending Jun 30, 2023
As of the most recent data (June 2023), PRDS shows a gross profit of $0. In the prior-year period, the figure was $0. That is below the sector sector average of $790M. Scroll down for historical charts and peer comparison views.
Compared with the year-ago period, PRDS's gross profit is now $0 (was $0). Pairing that YoY change with peer averages gives a clearer picture of whether Pardes Biosciences is outperforming or lagging.
The its sector sector average gross profit is about $790M. Pardes Biosciences is at $0, which is lower that average. That is roughly 100.0% below the sector mean. Use the comparison chart on this page to see how PRDS stacks up against individual peers as well.
Tracking PRDS's gross profit over time shows whether Pardes Biosciences is scaling, shrinking, or reshaping that part of the business. The current reading is $0 In the prior-year period, the figure was $0. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.
Besides this gross profit page, Stockcircle has Pardes Biosciences's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect gross profit (currently $0) with ownership activity and broader fundamentals.
